» Articles » PMID: 32294897

First-degree Relatives of Celiac Disease Patients Have Increased Seroreactivity to Serum Microbial Markers

Overview
Journal Nutrients
Date 2020 Apr 17
PMID 32294897
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Risk of celiac disease (CD) is increased in relatives of CD patients due to genetic and possible environmental factors. We recently reported increased seropositivity to anti- (ASCA), -associated sequence (anti-I2) and TonB-linked outer membrane protein (anti-OmpW) antibodies in CD. We hypothesized these markers also to be overrepresented in relatives. Seropositivity and levels of ASCA, anti-I2 and anti-OmpW were compared between 463 first-degree relatives, 58 untreated and 55 treated CD patients, and 80 controls. CD-associated human leukocyte antigen (HLA)-haplotypes and transglutaminase (tTGab) and endomysium (EmA) antibodies were determined. One or more of the microbial antibodies was present in 75% of relatives, 97% of untreated and 87% of treated CD patients and 44% of the controls. The relatives had higher median ASCA IgA (9.13 vs. 4.50 U/mL, < 0.001), ASCA IgG (8.91 vs. 5.75 U/mL, < 0.001) and anti-I2 (absorbance 0.74 vs. 0.32, < 0.001) levels than controls. There was a weak, positive correlation between tTGab and ASCA (r = 0.31, < 0.001). Seropositivity was not significantly associated with HLA. To conclude, seropositivity to microbial markers was more common and ASCA and anti-I2 levels higher in relatives of CD patients than controls. These findings were not associated with HLA, suggesting the role of other genetic and environmental factors.

Citing Articles

Coincidence of antibodies against Hwp1 and ASCA, two distinct molecular targets of , reinforces the link between this fungal species and coeliac disease.

Sendid B, Cao C, Colombel J, Poulain D Virulence. 2024; 15(1):2334085.

PMID: 38528835 PMC: 10968292. DOI: 10.1080/21505594.2024.2334085.


Advances in Celiac Disease and Gluten-Free Diet.

Comino I, Sousa C Nutrients. 2022; 14(3).

PMID: 35276929 PMC: 8839834. DOI: 10.3390/nu14030570.

References
1.
Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H . Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007; 26(9):1217-25. DOI: 10.1111/j.1365-2036.2007.03502.x. View

2.
Kemppainen K, Lynch K, Liu E, Lonnrot M, Simell V, Briese T . Factors That Increase Risk of Celiac Disease Autoimmunity After a Gastrointestinal Infection in Early Life. Clin Gastroenterol Hepatol. 2016; 15(5):694-702.e5. PMC: 5576726. DOI: 10.1016/j.cgh.2016.10.033. View

3.
Wijmenga C, Gutierrez-Achury J . Celiac disease genetics: past, present and future challenges. J Pediatr Gastroenterol Nutr. 2014; 59 Suppl 1:S4-7. DOI: 10.1097/01.mpg.0000450392.23156.10. View

4.
Pekki H, Kurppa K, Maki M, Huhtala H, Sievanen H, Laurila K . Predictors and Significance of Incomplete Mucosal Recovery in Celiac Disease After 1 Year on a Gluten-Free Diet. Am J Gastroenterol. 2015; 110(7):1078-85. DOI: 10.1038/ajg.2015.155. View

5.
Viitasalo L, Kurppa K, Ashorn M, Saavalainen P, Huhtala H, Ashorn S . Microbial Biomarkers in Patients with Nonresponsive Celiac Disease. Dig Dis Sci. 2018; 63(12):3434-3441. DOI: 10.1007/s10620-018-5285-z. View